EarlyIn VitroandIn VivoDevelopment of High-Level Daptomycin Resistance Is Common in Mitis Group Streptococci after Exposure to Daptomycin

Frequency of Occurrence and Daptomycin Susceptibility Rates of Gram-positive Organisms Causing Bloodstream

(2014) H.S. Sader et al.   JOURNAL OF CHEMOTHERAPY

Daptomycin Concentrations in Valve Tissue and Vegetation in Patients with Bacterial Endocarditis

(2012) Carlo Tascini et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Experience With Daptomycin for Outpatient Parenteral Antibiotic Therapy

(2011) Julius Larioza et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Breakthrough Bacteremia and Septic Shock Due to Streptococcus anginosus Resistant to Daptomycin in a Patient Receiving Daptomycin Therapy

(2011) Federico Palacio et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Genetic Basis for Daptomycin Resistance in Enterococci

(2011) Kelli L. Palmer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

(2011) Catherine Liu et al.   CLINICAL INFECTIOUS DISEASES

Clinical utility of daptomycin in infective endocarditis caused by Gram-positive cocci

(2011) Carlos Cervera et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy

(2011) F. K. Gould et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Genetic Basis for In Vivo Daptomycin Resistance in Enterococci

(2011) Cesar A. Arias et al.   NEW ENGLAND JOURNAL OF MEDICINE

Addition of Gentamicin or Rifampin Does Not Enhance the Effectiveness of Daptomycin in Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus

(2009) J. M. Miro et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st Century

(2009) David R. Murdoch   ARCHIVES OF INTERNAL MEDICINE

Actividad comparativa de daptomicina frente a microorganismos grampositivos: programa SENTRY España (2002-2006)

(2009) Elena Loza et al.   ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA

Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC)

(2009) et al.   EUROPEAN HEART JOURNAL

Developments in outpatient parenteral antimicrobial therapy (OPAT) for Gram-positive infections in Europe, and the potential impact of daptomycin

(2009) D. Nathwani   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Daptomycin Is Effective in Treatment of Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus

(2008) F. Marco et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY